Department of Dermatology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Selective internal radiotherapy and chemosaturation show equivalent survival in metastatic uveal melanoma: a retrospective multicenter study. (2026) Koch E, Schielein LA, Reitmajer M, Glaser AC, Drexler K, Franklin C, Forschner A, et al. Journal article Iodine provocation test Jodprovokationstest (2026) Sticherling M Journal article Tzanck test—still relevant? Tzanck-Test – noch zeitgemäß? (2026) Sticherling M Journal article Early Gut–Vascular Barrier Breakdown Precedes Colitis Onset in Murine Models (2026) Mohamed Abdou M, Kreiß L, Schmid B, Thoma OM, Krüger R, Bénard A, Müller T, et al. Journal article S1 Guideline: Therapy of generalized pustular psoriasis (2026) Mößner R, Cramer N, Gerdes S, Hüffmeier U, Körber A, Krause K, Kromer C, et al. Journal article Sorafenib as first-line therapy for metastatic uveal melanoma: A multicenter, placebo-controlled randomized discontinuation study (STREAM) (2025) Kalkavan H, Scheulen ME, Kämpgen E, Keilholz U, Heinzerling L, Lueong SS, Hlinka A, et al. Journal article Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany (2025) Heinrich L, Birkner T, Abraham S, Gerdes S, Honstein T, Müller S, Augustin M, et al. Journal article Gene expression and molecular pathway analyses differentiate immunotherapy-induced myositis from spontaneous dermatomyositis (2025) Röckel M, Musella L, Preusse C, Radke J, Zimmer L, Thoms KM, Dimitriou F, et al. Journal article Macrophages foster anti-tumor immunity by ZEB1-dependent cytotoxic T cell chemoattraction (2025) Fuchs K, D'Avanzo E, Armstark I, van Roey R, Clavel Ezquerra A, Bindel N, Siebenkäs K, et al. Journal article Association of HLA-A*02:01 type with efficacy and toxicity of immune checkpoint inhibitor therapy in melanoma patients: a retrospective cohort study (2025) Manger I, Schmitt C, Berking C, French LE, Vera González J, Heinzerling L Journal article